{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:00:42Z","timestamp":1784782842912,"version":"3.55.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deanship of Research and Graduate Studies at King Khalid University for funding this work through Small Research Project","award":["RGP1\/44\/46"],"award-info":[{"award-number":["RGP1\/44\/46"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05375-w","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:11:51Z","timestamp":1777954311000},"page":"14781-14805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanoparticle-mediated targeted delivery of lutein for retinal protection: emerging strategies in ocular drug targeting"],"prefix":"10.1007","volume":"399","author":[{"given":"Sambhavi","family":"Swarn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadma","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4085-8936","authenticated-orcid":false,"given":"Devesh U.","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"5375_CR1","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","volume":"309","author":"Age-Related Eye Disease Study 2 Research G","year":"2013","unstructured":"Age-Related Eye Disease Study 2 Research G (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309:2005\u20132015","journal-title":"JAMA"},{"key":"5375_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","volume":"6","author":"V Agrahari","year":"2016","unstructured":"Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, Hadji H, Mitra R, Pal D, Mitra AK (2016) A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res 6:735\u2013754","journal-title":"Drug Deliv Transl Res"},{"key":"5375_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.survophthal.2004.12.009","volume":"50","author":"SS Ahmed","year":"2005","unstructured":"Ahmed SS, Lott MN, Marcus DM (2005) The macular xanthophylls. Surv Ophthalmol 50:183\u2013193","journal-title":"Surv Ophthalmol"},{"key":"5375_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091852","volume":"14","author":"AH Algan","year":"2022","unstructured":"Algan AH, Gungor-Ak A, Karatas A (2022) Nanoscale delivery systems of lutein: An updated review from a pharmaceutical perspective. Pharmaceutics 14:1852","journal-title":"Pharmaceutics"},{"key":"5375_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/15376516.2024.2401924","volume":"35","author":"SP Banik","year":"2025","unstructured":"Banik SP, Kumar P, Basak P, Goel A, Ohia SE, Bagchi M, Chakraborty S, Kundu A, Bagchi D (2025) A critical insight into the physicochemical stability of macular carotenoids with respect to their industrial production, safety profile, targeted tissue delivery, and bioavailability. Toxicol Mech Methods 35:215\u2013229","journal-title":"Toxicol Mech Methods"},{"key":"5375_CR6","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1080\/17425247.2016.1201059","volume":"13","author":"L Battaglia","year":"2016","unstructured":"Battaglia L, Serpe L, Foglietta F, Muntoni E, Gallarate M, Del Pozo Rodriguez A, Solinis MA (2016) Application of lipid nanoparticles to ocular drug delivery. Expert Opin Drug Deliv 13:1743\u20131757","journal-title":"Expert Opin Drug Deliv"},{"key":"5375_CR7","doi-asserted-by":"publisher","unstructured":"Bejjani RA, Behar-Cohen F, Benezra D, Gurny R, Delie F (2005) Polymeric nanoparticles for drug delivery to the posterior segment of the eye. Chimia 59(6):344\u2013344. https:\/\/doi.org\/10.2533\/000942905777676281","DOI":"10.2533\/000942905777676281"},{"key":"5375_CR8","doi-asserted-by":"crossref","unstructured":"Bhat I, Mamatha BS (2022) Lutein: a nutraceutical nanoconjugate for human health. In: Nanopharmaceuticals in regenerative medicine. CRC Press, pp 189\u2013206","DOI":"10.1201\/9781003153504-11"},{"key":"5375_CR9","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.2147\/IJN.S269004","volume":"15","author":"M Bin-Jumah","year":"2020","unstructured":"Bin-Jumah M, Gilani SJ, Jahangir MA, Zafar A, Alshehri S, Yasir M, Kala C, Taleuzzaman M, Imam SS (2020) Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity. Int J Nanomedicine 15:7861\u20137875","journal-title":"Int J Nanomedicine"},{"key":"5375_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.nano.2018.09.016","volume":"15","author":"E Bodoki","year":"2019","unstructured":"Bodoki E, Vostinaru O, Samoila O, Dinte E, Bodoki AE, Swetledge S, Astete CE, Sabliov CM (2019) Topical nanodelivery system of lutein for the prevention of selenite-induced cataract. Nanomedicine (Lond) 15:188\u2013197","journal-title":"Nanomedicine (Lond)"},{"key":"5375_CR11","doi-asserted-by":"publisher","unstructured":"Bolla PK, Gote V, Singh M, Patel M, Clark BA, Renukuntla J (2002)\u00a0Lutein-loaded, biotin-decorated polymeric nanoparticles enhance lutein uptake in retinal cells. Pharmaceutics 12. https:\/\/doi.org\/10.3390\/pharmaceutics12090798","DOI":"10.3390\/pharmaceutics12090798"},{"key":"5375_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.abb.2010.06.019","volume":"504","author":"RA Bone","year":"2010","unstructured":"Bone RA, Landrum JT (2010) Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters. Arch Biochem Biophys 504:50\u201355","journal-title":"Arch Biochem Biophys"},{"key":"5375_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101685","author":"AM Burhan","year":"2021","unstructured":"Burhan AM, Klahan B, Cummins W, Andres-Guerrero V, Byrne ME, O\u2019Reilly NJ, Chauhan A, Fitzhenry L, Hughes H (2021) Posterior segment ophthalmic drug delivery: role of muco-adhesion with a special focus on chitosan. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13101685","journal-title":"Pharmaceutics"},{"key":"5375_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306640","volume":"19","author":"RT Carter","year":"2024","unstructured":"Carter RT, Swetledge S, Navarro S, Liu C-C, Ineck N, Lewin AC, Donnarumma F, Bodoki E, Stout RW, Astete C (2024) The impact of lutein-loaded poly (lactic-co-glycolic acid) nanoparticles following topical application: an in vitro and in vivo study. PLoS One 19:e0306640","journal-title":"PLoS One"},{"key":"5375_CR15","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-018-1256-0","volume":"20","author":"C Chittasupho","year":"2018","unstructured":"Chittasupho C, Posritong P, Ariyawong P (2018) Stability, cytotoxicity, and retinal pigment epithelial cell binding of hyaluronic acid-coated PLGA nanoparticles encapsulating lutein. AAPS PharmSciTech 20:4","journal-title":"AAPS PharmSciTech"},{"key":"5375_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1877912311202020082","volume":"2","author":"K Cholkar","year":"2012","unstructured":"Cholkar K, Patel A, Vadlapudi AD, Mitra AK (2012) Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery. Recent Pat Nanomed 2:82\u201395","journal-title":"Recent Pat Nanomed"},{"key":"5375_CR17","doi-asserted-by":"publisher","unstructured":"Chung H-Y, Rasmussen HM, Johnson EJ (2004) Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. American Society for Nutritional Sciences (ASNS), pp 1883\u20131893. https:\/\/doi.org\/10.1093\/jn\/134.8.1887","DOI":"10.1093\/jn\/134.8.1887"},{"key":"5375_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0140-6736(22)01839-6","volume":"401","author":"MV Cicinelli","year":"2023","unstructured":"Cicinelli MV, Buchan JC, Nicholson M, Varadaraj V, Khanna RC (2023) Cataracts. Lancet 401:377\u2013389","journal-title":"Lancet"},{"key":"5375_CR19","doi-asserted-by":"publisher","unstructured":"Conn PF, Schalch W, Truscott TG (1991) The singlet oxygen and carotenoid interaction, vol 11. Elsevier Sequoia, Lausanne, pp 41\u201347. https:\/\/doi.org\/10.1016\/1011-1344(91)80266-K","DOI":"10.1016\/1011-1344(91)80266-K"},{"key":"5375_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1124\/pr.117.014753","volume":"70","author":"A Cuadrado","year":"2018","unstructured":"Cuadrado A, Manda G, Hassan A, Alcaraz MJ, Barbas C, Daiber A, Ghezzi P, Leon R, Lopez MG, Oliva B, Pajares M, Rojo AI, Robledinos-Anton N, Valverde AM, Guney E, Schmidt H (2018) Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach. Pharmacol Rev 70:348\u2013383","journal-title":"Pharmacol Rev"},{"key":"5375_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.26599\/FSHW.2022.9250138","volume":"13","author":"Z Dai","year":"2024","unstructured":"Dai Z, Nie M, Chen Y, Song J, Xu Y, Zhang Z, Zhang G, Yan S, Zhang X, Li D (2024) Lutein-stevioside nanoparticle attenuates H2O2-induced oxidative damage in ARPE cells. Food Sci Hum Wellness 13:1628\u20131635","journal-title":"Food Sci Hum Wellness"},{"key":"5375_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00210-024-03376-1","volume":"398","author":"A Das","year":"2025","unstructured":"Das A, Shahriar TG, Zehravi M, Sweilam SH, Alshehri MA, Ahmad I, Nafady MH, Emran TB (2025) Clinical management of eye diseases: carotenoids and their nanoformulations as choice of therapeutics. Naunyn Schmiedebergs Arch Pharmacol 398:329\u2013349","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5375_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/photochem2020022","volume":"2","author":"B Demmig-Adams","year":"2022","unstructured":"Demmig-Adams B, Polutchko SK, Adams WW (2022) Structure-function-environment relationship of the isomers zeaxanthin and lutein. Photochem 2:308\u2013325","journal-title":"Photochem"},{"key":"5375_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4274\/tjps.galenos.2020.59319","volume":"18","author":"RK Dhahir","year":"2021","unstructured":"Dhahir RK, Al-Nima AM, Al-Bazzaz FY (2021) Nanoemulsions as ophthalmic drug delivery systems. Turk J Pharm Sci 18:652\u2013664","journal-title":"Turk J Pharm Sci"},{"key":"5375_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.abb.2004.03.024","volume":"430","author":"A During","year":"2004","unstructured":"During A, Harrison EH (2004) Intestinal absorption and metabolism of carotenoids: insights from cell culture. Arch Biochem Biophys 430:77\u201388","journal-title":"Arch Biochem Biophys"},{"key":"5375_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1039\/c6pp00134c","volume":"15","author":"E Fernandez-Garcia","year":"2016","unstructured":"Fernandez-Garcia E, Carvajal-Lerida I, Perez-Galvez A (2016) Carotenoids exclusively synthesized in red pepper (capsanthin and capsorubin) protect human dermal fibroblasts against UVB induced DNA damage. Photochem Photobiol Sci 15:1204\u20131211","journal-title":"Photochem Photobiol Sci"},{"key":"5375_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911769","volume":"23","author":"RM Galindo-Camacho","year":"2022","unstructured":"Galindo-Camacho RM, Blanco-Llamero C, da Ana R, Fuertes MA, Se\u00f1or\u00e1ns FJ, Silva AM, Garc\u00eda ML, Souto EB (2022) Therapeutic approaches for age-related macular degeneration. Int J Mol Sci 23:11769","journal-title":"Int J Mol Sci"},{"key":"5375_CR28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK (2010) Ocular drug delivery. AAPS J 12:348\u2013360","journal-title":"AAPS J"},{"key":"5375_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.abb.2018.04.008","volume":"647","author":"E Giordano","year":"2018","unstructured":"Giordano E, Quadro L (2018) Lutein, zeaxanthin and mammalian development: metabolism, functions and implications for health. Arch Biochem Biophys 647:33\u201340","journal-title":"Arch Biochem Biophys"},{"key":"5375_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/17425255.2020.1803278","volume":"16","author":"V Gote","year":"2020","unstructured":"Gote V, Ansong M, Pal D (2020) Prodrugs and nanomicelles to overcome ocular barriers for drug penetration. Expert Opin Drug Metab Toxicol 16:885\u2013906","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5375_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2020.102342","volume":"288","author":"B Grassiri","year":"2021","unstructured":"Grassiri B, Zambito Y, Bernkop-Schnurch A (2021) Strategies to prolong the residence time of drug delivery systems on ocular surface. Adv Colloid Interface Sci 288:102342","journal-title":"Adv Colloid Interface Sci"},{"key":"5375_CR32","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1364\/JOSAA.14.001187","volume":"14","author":"BRJ Hammond","year":"1997","unstructured":"Hammond BRJ (1997) Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A 14:1187\u20131196","journal-title":"J Opt Soc Am A"},{"key":"5375_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-024-0945-1_1","volume":"81","author":"EH Harrison","year":"2016","unstructured":"Harrison EH, Curley RW Jr. (2016) Carotenoids and retinoids: nomenclature, chemistry, and analysis. Subcell Biochem 81:1\u201319","journal-title":"Subcell Biochem"},{"key":"5375_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1248\/bpb.28.1","volume":"28","author":"KI Hosoya","year":"2005","unstructured":"Hosoya KI, Tomi M (2005) Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. Biol Pharm Bull 28:1\u20138","journal-title":"Biol Pharm Bull"},{"key":"5375_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/978-1-4614-4711-5_3","volume":"763","author":"M Humphries","year":"2013","unstructured":"Humphries M (2013) The blood-retina barrier. Adv Exp Med Biol 763:70\u201384","journal-title":"Adv Exp Med Biol"},{"key":"5375_CR36","doi-asserted-by":"publisher","unstructured":"Jacob S, Nair AB, Shah J, Gupta S, Boddu SHS, Sreeharsha N et al (2022) Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy-an overview on recent advances. Pharmaceutics 14(3):533. https:\/\/doi.org\/10.3390\/pharmaceutics14030533","DOI":"10.3390\/pharmaceutics14030533"},{"key":"5375_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1523-5408.2002.00004.x","volume":"5","author":"EJP Johnson","year":"2002","unstructured":"Johnson EJP (2002) The role of carotenoids in human health. Nutr Clin Care 5:56\u201365","journal-title":"Nutr Clin Care"},{"key":"5375_CR38","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3390\/molecules16021710","volume":"16","author":"HE Khoo","year":"2011","unstructured":"Khoo HE, Prasad KN, Kong KW, Jiang Y, Ismail A (2011) Carotenoids and their isomers: color pigments in fruits and vegetables. Molecules 16:1710\u20131738","journal-title":"Molecules"},{"key":"5375_CR39","doi-asserted-by":"publisher","unstructured":"Khoshnood N, Frampton JP, Badri A, Zamanian A (2024) 3D bioprinting of betamethasone-loaded gellan gum\u2013polyethyleneimine composite hydrogels for ocular drug delivery. IJB 10(4):3440. https:\/\/doi.org\/10.36922\/ijb.3440","DOI":"10.36922\/ijb.3440"},{"key":"5375_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.nutr.23.011702.073307","volume":"23","author":"NI Krinsky","year":"2003","unstructured":"Krinsky NI, Landrum JT, Bone RA (2003) Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23:171\u2013201","journal-title":"Annu Rev Nutr"},{"key":"5375_CR41","first-page":"505","volume":"43","author":"P Kumar","year":"2024","unstructured":"Kumar P, Banik SP, Ohia SE, Moriyama H, Chakraborty S, Wang C-K, Song YS, Goel A, Bagchi M, Bagchi D (2024) Current insights on the photoprotective mechanism of the macular carotenoids, lutein and zeaxanthin: safety, efficacy and bio-delivery. J Am Nutr Assoc 43:505\u2013518","journal-title":"J Am Nutr Assoc"},{"key":"5375_CR42","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1167\/iovs.12-10007","volume":"53","author":"S-Y Li","year":"2012","unstructured":"Li S-Y, Fung FKC, Fu ZJ, Wong D, Chan HHL, Lo ACY (2012) Anti-inflammatory effects of lutein in retinal ischemic\/hypoxic injury. In vivo and in vitro studies. Invest Ophthalmol Vis Sci 53:5976\u20135984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5375_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2022.112617","volume":"238","author":"X Li","year":"2023","unstructured":"Li X, Zhu S, Qi F (2023) Blue light pollution causes retinal damage and degeneration by inducing ferroptosis. J Photochem Photobiol B 238:112617","journal-title":"J Photochem Photobiol B"},{"key":"5375_CR44","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1021\/acs.jafc.3c09054","volume":"72","author":"K Liu","year":"2024","unstructured":"Liu K, Zhang X, Liu R, Su W, Song Y, Tan M (2024a) Preparation of lutein nanoparticles by glycosylation of saccharides and casein for protecting retinal pigment epithelial cells. J Agric Food Chem 72:6347\u20136359","journal-title":"J Agric Food Chem"},{"key":"5375_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.147590","volume":"479","author":"R Liu","year":"2024","unstructured":"Liu R, Fei S, Zhang X, Hua Z, Tan M (2024b) Layer-by-layer oral-deliverable nanoparticles targeted microfold cells to promote lutein absorption in alleviating dry eye disease. Chem Eng J 479:147590","journal-title":"Chem Eng J"},{"key":"5375_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.153024","volume":"494","author":"R Liu","year":"2024","unstructured":"Liu R, Zhang X, Fei S, Tan M (2024c) Orally deliverable lutein nanoparticles as robust ROS scavenger for dry eye disease by targeting Peyer\u2019s patches and mitochondria of ocular cell. Chem Eng J 494:153024","journal-title":"Chem Eng J"},{"key":"5375_CR47","doi-asserted-by":"publisher","first-page":"19255","DOI":"10.1021\/acsnano.5c01673","volume":"19","author":"K Liu","year":"2025","unstructured":"Liu K, Shen Y, Chen S, Su W, Song Y, Tan M (2025) Stimulus-responsive targeted lutein nanoparticles for the alleviation of blue light-induced retinal degeneration. ACS Nano 19:19255\u201319273","journal-title":"ACS Nano"},{"key":"5375_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jsfa.3785","volume":"90","author":"L Ma","year":"2010","unstructured":"Ma L, Lin XM (2010) Effects of lutein and zeaxanthin on aspects of eye health. J Sci Food Agric 90:2\u201312","journal-title":"J Sci Food Agric"},{"key":"5375_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/coatings12101449","volume":"12","author":"Y Ma","year":"2022","unstructured":"Ma Y, You T, Wang J, Jiang Y, Niu J (2022) Research progress on construction of lutein-loaded nano delivery system and their improvements on the bioactivity. Coatings 12:1449","journal-title":"Coatings"},{"key":"5375_CR50","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1080\/10408398.2020.1867958","volume":"62","author":"S Maghsoudi","year":"2022","unstructured":"Maghsoudi S, Taghavi Shahraki B, Rabiee N, Fatahi Y, Bagherzadeh M, Dinarvand R, Ahmadi S, Rabiee M, Tahriri M, Hamblin MR (2022) The colorful world of carotenoids: a profound insight on therapeutics and recent trends in nano delivery systems. Crit Rev Food Sci Nutr 62:3658\u20133697","journal-title":"Crit Rev Food Sci Nutr"},{"key":"5375_CR51","first-page":"1","volume":"2","author":"M Maghsoudloo","year":"2023","unstructured":"Maghsoudloo M, Bagheri Shahzadeh Aliakbari R (2023) Lutein with various therapeutic activities based on micro and nanoformulations: a systematic mini-review. Micro Nano Bio Aspects 2:1\u20137","journal-title":"Micro Nano Bio Aspects"},{"key":"5375_CR52","doi-asserted-by":"publisher","unstructured":"Mahaling B, Baruah N, Dinabandhu A (2024) Nanomedicine in ophthalmology: from bench to bedside. J Clin Med 13(24):7651. https:\/\/doi.org\/10.3390\/jcm13247651","DOI":"10.3390\/jcm13247651"},{"key":"5375_CR53","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","volume":"58","author":"E Mannermaa","year":"2006","unstructured":"Mannermaa E, Vellonen KS, Urtti A (2006) Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136\u20131163","journal-title":"Adv Drug Deliv Rev"},{"key":"5375_CR54","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1007\/s11694-023-01962-0","volume":"17","author":"A Mehmood","year":"2023","unstructured":"Mehmood A, Zeb A (2023) Effects of different cooking techniques on the carotenoids composition, phenolic contents, and antioxidant activity of spinach leaves. J Food Meas Charact 17:4760\u20134774","journal-title":"J Food Meas Charact"},{"key":"5375_CR55","first-page":"70","volume":"15","author":"LD Miricescu","year":"2020","unstructured":"Miricescu LD, Totan A, Virgolici LH, Greabu M, Mohora M (2020) The ocular protective effects of PLGA nanoparticles loaded with lutein, in fat diet Wistar rats, treated with sistemic glucocorticoids. Rom J Med Pract 15:70","journal-title":"Rom J Med Pract"},{"key":"5375_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052892","volume":"25","author":"E Montuori","year":"2024","unstructured":"Montuori E, Lima S, Marchese A, Scargiali F, Lauritano C (2024) Lutein production and extraction from microalgae: recent insights and bioactive potential. Int J Mol Sci 25:2892","journal-title":"Int J Mol Sci"},{"key":"5375_CR57","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1021\/jf991106k","volume":"48","author":"YMA Naguib","year":"2000","unstructured":"Naguib YMA (2000) Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 48:1150\u20131154","journal-title":"J Agric Food Chem"},{"key":"5375_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248857","volume":"16","author":"AB Nair","year":"2021","unstructured":"Nair AB, Shah J, Jacob S, Al-Dhubiab BE, Sreeharsha N, Morsy MA, Gupta S, Attimarad M, Shinu P, Venugopala KN (2021b) Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections. PLoS One 16:e0248857","journal-title":"PLoS One"},{"key":"5375_CR59","doi-asserted-by":"crossref","unstructured":"Nair A, Shah J, Al-Dhubiab B, Jacob S, Patel S, Venugopala K, Morsy M, Gupta S, Attimarad M, Sreeharsha N, Shinu P (2021a) Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies. Pharmaceutics 13","DOI":"10.3390\/pharmaceutics13040523"},{"key":"5375_CR60","doi-asserted-by":"publisher","unstructured":"Navarro-Partida J, Castro-Castaneda CR, Santa Cruz-Pavlovich FJ, Aceves-Franco LA, Guy TO, Santos A (2021) Lipid-based nanocarriers as topical drug delivery systems for intraocular diseases. Pharmaceutics 13(5):678. https:\/\/doi.org\/10.3390\/pharmaceutics13050678","DOI":"10.3390\/pharmaceutics13050678"},{"key":"5375_CR61","doi-asserted-by":"crossref","unstructured":"Naylor A, Hopkins A, Hudson N, Campbell M (2019) Tight junctions of the outer blood retina barrier. Int J Mol Sci 21","DOI":"10.3390\/ijms21010211"},{"key":"5375_CR62","doi-asserted-by":"publisher","first-page":"53327","DOI":"10.1021\/acsami.5c14464","volume":"17","author":"D Nguyen","year":"2025","unstructured":"Nguyen D, Sarkar S, Thrimawithana T, Piva T, Conn CE, Luu C, Huynh T (2025) Optimizing lutein formulations for targeted ocular drug delivery. In vitro and in vivo insights. ACS Appl Mater Interfaces 17:53327\u201353342","journal-title":"ACS Appl Mater Interfaces"},{"key":"5375_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020162","volume":"18","author":"A Nikolaidou","year":"2025","unstructured":"Nikolaidou A, Spyratou E, Sandali A, Gianni T, Platoni K, Lamprogiannis L, Efstathopoulos EP (2025) Utilization of nanoparticles for treating age-related macular degeneration. Pharmaceuticals (Basel) 18:162","journal-title":"Pharmaceuticals (Basel)"},{"key":"5375_CR64","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.5530\/pj.2020.12.239","volume":"12","author":"NI Nurul Fuad","year":"2020","unstructured":"Nurul Fuad NI, Sekar M, Gan SH, Lum PT, Vaijanathappa J, Ravi S (2020) Lutein: a comprehensive review on its chemical, biological activities and therapeutic potentials. Pharmacogn J 12:1769\u20131778","journal-title":"Pharmacogn J"},{"key":"5375_CR65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tifs.2015.12.005","volume":"49","author":"ID Nwachukwu","year":"2016","unstructured":"Nwachukwu ID, Udenigwe CC, Aluko RE (2016) Lutein and zeaxanthin: production technology, bioavailability, mechanisms of action, visual function, and health claim status. Trends Food Sci Technol 49:74\u201384","journal-title":"Trends Food Sci Technol"},{"key":"5375_CR66","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nutres.2007.04.002","volume":"27","author":"OF O\u2019Connell","year":"2007","unstructured":"O\u2019Connell OF, Ryan L, O\u2019Brien NM (2007) Xanthophyll carotenoids are more bioaccessible from fruits than dark green vegetables. Nutr Res 27:258\u2013264","journal-title":"Nutr Res"},{"key":"5375_CR67","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/antiox10030363","volume":"10","author":"R Pap","year":"2002","unstructured":"Pap R, Pandur E, J\u00e1nosa G, Sipos K, Ag\u00f3cs A, Deli J (2002) Lutein exerts antioxidant and anti-inflammatory effects and influences iron utilization of BV-2 microglia. Antioxidants (Basel) 10:363. https:\/\/doi.org\/10.3390\/antiox10030363","journal-title":"Antioxidants (Basel)"},{"key":"5375_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel A, Cholkar K, Agrahari V, Mitra AK (2013) Ocular drug delivery systems: an overview. World J Pharmacol 2:47\u201364","journal-title":"World J Pharmacol"},{"key":"5375_CR69","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1134\/S0965545X24601047","volume":"66","author":"L Peng","year":"2024","unstructured":"Peng L, Dong L, Cai T, Liu K, Gao X, Sun W, Li A, Song X (2024) Hyaluronic acid modified lutein nanoparticles for effective application in eye drops: development, characterization, and evaluation. Polym Sci Ser A Chem Phys 66:480\u2013490","journal-title":"Polym Sci Ser A Chem Phys"},{"key":"5375_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.850757","volume":"10","author":"MS Razavi","year":"2022","unstructured":"Razavi MS, Ebrahimnejad P, Fatahi Y, D\u2019Emanuele A, Dinarvand R (2022) Recent developments of nanostructures for the ocular delivery of natural compounds. Front Chem 10:850757","journal-title":"Front Chem"},{"key":"5375_CR71","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.3390\/nu5093563","volume":"5","author":"E Reboul","year":"2013","unstructured":"Reboul E (2013) Absorption of vitamin A and carotenoids by the enterocyte: focus on transport proteins. Nutrients 5:3563\u20133581","journal-title":"Nutrients"},{"key":"5375_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102075","author":"M Said","year":"2021","unstructured":"Said M, Aboelwafa AA, Elshafeey AH, Elsayed I (2021) Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2020.102075","journal-title":"J Drug Deliv Sci Technol"},{"key":"5375_CR73","doi-asserted-by":"publisher","unstructured":"Savvidou G (2022\u20132023) The new era of nanomedicine in neuro-ophthalmology. Hellenic Republic National and Kapodistrian University of Athens, p 56. https:\/\/doi.org\/10.21926\/rpm.2403022","DOI":"10.21926\/rpm.2403022"},{"key":"5375_CR74","doi-asserted-by":"publisher","first-page":"20","DOI":"10.51847\/TBlH98sXcQ","volume":"15","author":"SM Seethamraju","year":"2024","unstructured":"Seethamraju SM, Nori LP (2024) Obstruction and approaches to cross the drug molecules through Blood Retinal Barrier: an overview. Pharmacophore 15:20\u201332","journal-title":"Pharmacophore"},{"key":"5375_CR75","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41419-020-02950-8","volume":"11","author":"N Seiwert","year":"2020","unstructured":"Seiwert N, Wecklein S, Demuth P, Hasselwander S, Kemper TA, Schwerdtle T, Brunner T, Fahrer J (2020) Heme oxygenase 1 protects human colonocytes against ROS formation, oxidative DNA damage and cytotoxicity induced by heme iron, but not inorganic iron. Cell Death Dis 11:787","journal-title":"Cell Death Dis"},{"key":"5375_CR76","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12247-021-09537-6","volume":"17","author":"S Shah","year":"2022","unstructured":"Shah S, Bhanderi B, Soniwala M, Chavda J (2022) Lutein-loaded solid lipid nanoparticles for ocular delivery: statistical optimization and ex vivo evaluation. J Pharm Innov 17:584\u2013598","journal-title":"J Pharm Innov"},{"key":"5375_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010205","author":"DH Shastri","year":"2023","unstructured":"Shastri DH, Silva AC, Almeida H (2023) Ocular delivery of therapeutic proteins: a review. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15010205","journal-title":"Pharmaceutics"},{"key":"5375_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202314095","volume":"36","author":"J Shen","year":"2024","unstructured":"Shen J, Chen L, Lv X, Liu N, Miao Y, Zhang Q, Xiao Z, Li M, Yang Y, Liu Z, Chen Q (2024) Emerging co-assembled and sustained released natural medicinal nanoparticles for multitarget therapy of choroidal neovascularization. Adv Mater 36:2314095","journal-title":"Adv Mater"},{"key":"5375_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/07853890.2022.2157477","volume":"55","author":"J Sheppard","year":"2023","unstructured":"Sheppard J, Shen Lee B, Periman LM (2023) Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann Med 55:241\u2013252","journal-title":"Ann Med"},{"key":"5375_CR80","doi-asserted-by":"publisher","first-page":"10611","DOI":"10.1007\/s00210-025-03919-0","volume":"398","author":"R Shetty","year":"2025","unstructured":"Shetty R, Jose J, Maliyakkal N, S DS, Johnson RP, Bandiwadekar A, Gopan G, Ugare SR, Preman NK (2025) Micelle nanogel\u2013based drug delivery system for lutein in ocular administration. Naunyn Schmiedebergs Arch Pharmacol 398:10611\u201310623","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5375_CR81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/2211738511666230816090046","volume":"12","author":"D Shree","year":"2024","unstructured":"Shree D, Patra CN, Sahoo BM (2024) Applications of nanotechnology-mediated herbal nanosystems for ophthalmic drug. Pharm Nanotechnol 12:229\u2013250","journal-title":"Pharm Nanotechnol"},{"key":"5375_CR82","doi-asserted-by":"publisher","unstructured":"Souto EB, Dias-Ferreira J, Lopez-Machado A, Ettcheto M, Cano A, Camins Espuny A et al (2019) Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents. Pharmaceutics 11(9). https:\/\/doi.org\/10.3390\/pharmaceutics11090460","DOI":"10.3390\/pharmaceutics11090460"},{"key":"5375_CR83","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","volume":"24","author":"A Subrizi","year":"2019","unstructured":"Subrizi A, Del Amo EM, Korzhikov-Vlakh V, Tennikova T, Ruponen M, Urtti A (2019) Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties. Drug Discov Today 24:1446\u20131457","journal-title":"Drug Discov Today"},{"key":"5375_CR84","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM (2016) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99:28\u201351","journal-title":"Adv Drug Deliv Rev"},{"key":"5375_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90792-5","volume":"11","author":"S Swetledge","year":"2021","unstructured":"Swetledge S, Carter R, Stout R, Astete CE, Jung JP, Sabliov CM (2021) Stability and ocular biodistribution of topically administered PLGA nanoparticles. Sci Rep 11:12270","journal-title":"Sci Rep"},{"key":"5375_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102362","volume":"62","author":"F Tan","year":"2021","unstructured":"Tan F, Cui H, Bai C, Qin C, Xu L, Han J (2021) Preparation, optimization, and transcorneal permeability study of lutein-loaded solid lipid nanoparticles. J Drug Deliv Sci Technol 62:102362","journal-title":"J Drug Deliv Sci Technol"},{"key":"5375_CR87","doi-asserted-by":"publisher","unstructured":"Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL (2018) Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci 19(9):2830. https:\/\/doi.org\/10.3390\/ijms19092830","DOI":"10.3390\/ijms19092830"},{"key":"5375_CR88","doi-asserted-by":"publisher","unstructured":"Tsung TH, Chen YH, Lu DW (2023a) Updates on biodegradable formulations for ocular drug delivery. Pharmaceutics 15(3):734. https:\/\/doi.org\/10.3390\/pharmaceutics15030734","DOI":"10.3390\/pharmaceutics15030734"},{"key":"5375_CR89","doi-asserted-by":"crossref","unstructured":"Tsung TH, Tsai YC, Lee HP, Chen YH, Lu DW (2023b) Biodegradable polymer-based drug-delivery systems for ocular diseases. Int J Mol Sci 24","DOI":"10.3390\/ijms241612976"},{"key":"5375_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4155\/tde.12.122","volume":"4","author":"AD Vadlapudi","year":"2013","unstructured":"Vadlapudi AD, Mitra AK (2013) Nanomicelles: an emerging platform for drug delivery to the eye. Ther Deliv 4:1\u20133","journal-title":"Ther Deliv"},{"key":"5375_CR91","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/bdd.2276","volume":"42","author":"B Williamson","year":"2021","unstructured":"Williamson B, Pilla Reddy V (2021) Blood retinal barrier and ocular pharmacokinetics: considerations for the development of oncology drugs. Biopharm Drug Dispos 42:128\u2013136","journal-title":"Biopharm Drug Dispos"},{"key":"5375_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.149898","volume":"486","author":"S Wu","year":"2024","unstructured":"Wu S, Su W, Wang K, Li H, Huang S, Tie S, Tan M (2024) Milk-derived exosome as delivery system for lutein encapsulation in alleviating dry eye disease. Chem Eng J 486:149898","journal-title":"Chem Eng J"},{"key":"5375_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.727870","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang S, Zhou J, Li D (2021) Functions and diseases of the retinal pigment epithelium. Front Pharmacol 12:727870","journal-title":"Front Pharmacol"},{"key":"5375_CR94","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1021\/acsmaterialslett.4c02327","volume":"7","author":"L Yang","year":"2025","unstructured":"Yang L, Li J, Zhou B, Wang Y (2025) An injectable copolymer for in situ lubrication effectively relieves dry eye disease. ACS Mater Lett 7:884\u2013890","journal-title":"ACS Mater Lett"},{"key":"5375_CR95","doi-asserted-by":"crossref","unstructured":"Yeo D, Hwang SH, Lee S, Jeong J, Kong J, Lee H, Smith L et al (2025) Global, regional and national burden of major blindness-associated ophthalmologic conditions, 1990\u20132021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Br J Ophthalmol","DOI":"10.1136\/bjo-2025-327917"},{"key":"5375_CR96","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/acs.molpharmaceut.2c00882","volume":"20","author":"M Zeng","year":"2023","unstructured":"Zeng M, Guo D, Fern\u00e1ndez-Varo G, Zhang X, Fu S, Ju S, Yang H, Liu X, Wang Y-C, Zeng Y, Casals G, Casals E (2023) The integration of nanomedicine with Traditional Chinese Medicine: drug delivery of natural products and other opportunities. Mol Pharm 20:886\u2013904","journal-title":"Mol Pharm"},{"key":"5375_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1565382","volume":"16","author":"CL Zhang","year":"2025","unstructured":"Zhang CL, Ma JJ, Li X, Yan HQ, Gui YK, Yan ZX, You MF, Zhang P (2025) The role of transcytosis in the blood-retina barrier: from pathophysiological functions to drug delivery. Front Pharmacol 16:1565382","journal-title":"Front Pharmacol"},{"key":"5375_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192511","volume":"13","author":"C Zhao","year":"2018","unstructured":"Zhao C, Shen X, Guo M (2018) Stability of lutein encapsulated whey protein nano-emulsion during storage. PLoS One 13:e0192511","journal-title":"PLoS One"},{"key":"5375_CR99","doi-asserted-by":"publisher","unstructured":"Zingale E, Bonaccorso A, D'Amico AG, Lombardo R, D'Agata V, Rautio J et al (2024) Formulating resveratrol and melatonin self-nanoemulsifying drug delivery systems (SNEDDS) for ocular administration using design of experiments. Pharmaceutics 16(1):125. https:\/\/doi.org\/10.3390\/pharmaceutics16010125","DOI":"10.3390\/pharmaceutics16010125"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05375-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05375-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05375-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:02:12Z","timestamp":1784779332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05375-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5375"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05375-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI models such as Grammarly and QuillBot has been used for the refinement of English Language in this manuscript.","order":2,"name":"Ethics","label":"AI utilization","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Clinical trials","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.Rest of the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}